Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Clinical trial NCT02107755 · COMPLETED

Trial details

NCT number: NCT02107755
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Metastases Lung Metastases Recurrent Melanoma Stage IV Melanoma Tumors Metastatic to Brain

Start date: 2014-09-05
Primary completion: 2020-08-03
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.